In 1992, Igarashi et al. showed that CD8+/CD11- cells, which inhibit antibody production, increased and CD4+/CD45RA- cells, which introduced antibody-producing cells, decreased along with tumor progression [39]. Here, CD8A is linked to neoplasm.